Yoo, Dae Hyun

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. [electronic resource] - Annals of the rheumatic diseases Oct 2013 - 1613-20 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1468-2060

10.1136/annrheumdis-2012-203090 doi


Adolescent
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--blood
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Immunoglobulin G--adverse effects
Infliximab
Male
Methotrexate--therapeutic use
Middle Aged
Severity of Illness Index
Treatment Outcome
Young Adult